SCHEMBL20054462

SCHEMBL20054462

CC(C)(C)OC(=O)NC(c1ncc(-c2ccc3cc(C#CC#Cc4ccc5cc(-c6cnc(C(NC(=O)OC(C)(C)C)C(C)(C)C)[nH]6)ccc5c4)ccc3c2)[nH]1)C(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SSTR3 P32745 1/20 0.40
GABRA1 P14867 2/20 0.39
GABRG2 P18507 2/20 0.39
GABRB3 P28472 2/20 0.39
GABRA3 P34903 2/20 0.39
GABRA2 P47869 2/20 0.39
GABRA5 P31644 1/20 0.39
GABRA4 P48169 1/20 0.39
GABRA6 Q16445 1/20 0.39
GABRB1 P18505 1/20 0.35
GABRB2 P47870 1/20 0.35
HDAC1 Q13547 11/20 0.35
AAK1 Q2M2I8 1/20 0.35
GSK3B P49841 1/20 0.34
DYRK1A Q13627 1/20 0.34
HDAC3 O15379 4/20 0.34
HDAC2 Q92769 3/20 0.34
HDAC6 Q9UBN7 2/20 0.34
HDAC4 P56524 1/20 0.34
HDAC7 Q8WUI4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15116775 1.00 SSTR3 (0.40) SSTR3GABRA1GABRG2GABRB3GABRA3
SCHEMBL16409154 0.96 SSTR3 (0.41) SSTR3GABRA1GABRG2GABRB3GABRA3
SCHEMBL15116767 0.92 GABRA1 (0.42) SSTR3GABRA1GABRG2GABRB3GABRA3
SCHEMBL20054356 0.92 SSTR3 (0.39) SSTR3GABRA1GABRG2GABRB3GABRA3
SCHEMBL15116773 0.92 SSTR3 (0.39) SSTR3GABRA1GABRG2GABRB3GABRA3
SCHEMBL20054377 0.89 SSTR3 (0.44) SSTR3GABRB1GABRB2HDAC1AAK1
SCHEMBL15116811 0.89 SSTR3 (0.44) SSTR3GABRB1GABRB2HDAC1AAK1
SCHEMBL12117653 0.88 SSTR3 (0.46) SSTR3GABRB1GABRB2HDAC1AAK1
SCHEMBL19414754 0.88 SSTR3 (0.46) SSTR3GABRB1GABRB2HDAC1AAK1
SCHEMBL15116447 0.86 SSTR3 (0.47) SSTR3GABRA1GABRG2GABRB3GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2802326-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2018-04-18 EP disclosed